One hundred patients whose hypertension was originally well controlled were carefully screened when a routine clinic visit showed that their blood pressure was above 170/100 mm Hg. Simple misconceptions accounted for 75 failures: 38 did not know they had to continue their drugs, 14 thought they should not take antihypertensive drugs if they had not had a meal, 13 did not know which drugs controlled their blood pressure, and 10 believed it was better not to take their drugs on clinic days.
Introduction
Hypertension may fail to respond to treatment for many reasons. The patient may be unreliable in taking drugs either regularly or as prescribed. He may be too poor to be able to afford them. He is often ignorant of the fact that treatment is life long and may stop it when symptoms are relieved. Injudicious advice is sometimes given by a doctor to stop treatment on the basis of a single normal blood pressure measurement. The 
Results
The 100 patients were aged between 30 and 90 years (mean 53 years). The mean age of the 67 women was slightly lower (46 years) than that of the 33 men (62-2 years). Duration of treatment before failure ranged from two months to nine years, with an average of nine months, but more than 80% of all failures occurred within the first year of clinic attendance.
About 60% of the women, although married, had an independent but largely inadequate means of livelihood, mostly by petty trading or working as cleaners in offices. Two thirds earned less than £840 a year. The remainder were dependent on husbands or relations, most of whom earned between £1680 and £2500 a year. Nearly 90% of all women and over 80% of men were in the lower socioeconomic groups.
CAUSES OF FAILURE
Fifty one patients admitted having some drugs: 25 had the full complement of prescribed antihypertensive drugs, 15 had some of them, and 11 had drugs which were irrelevant to treatment of hypertension, such as antidiabetic tablets, analgesics, vitamins, and haematinics.
Twenty four patients had taken drugs that morning, including 11 who took all the prescribed antihypertensive agents and seven who took only part of their treatment because some drugs were finished; the remaining six patients took various drugs with no antihypertensive effect.
Twenty seven patients did not take any drug that morning, although they had some, (a) because they had not had a meal, having left home early to attend the clinic (14), (b) because they thought they should not take drugs when coming to the hospital (11), or (c) because of intolerable side effects (3).
The 11 patients who took all their antihypertensive drugs and yet did not achieve adequate control had prescriptions for Aldomet (methyldopa) 250-500 mg three or four times daily, Moduretic (hydrochlorothiazide 50 mg and amiloride hydrochloride 5 mg combined) 1-2 tablets in the morning, and Valium (diazepam) Lagos General Hospital, Nigeria, West Africa 0 OGUNYEMI, MB, BS, MRCP, chief consultant physician 10 mg at night. The dose of methyldopa in the first four patients had already been increased several times, and a change to another drug was being contemplated. At this stage it was noticed that a generic methyldopa with a dusky yellow colour was being used and not Aldomet. When the bright yellow Aldomet tablet inscribed MSD was substituted, adequate control of blood pressure was achieved within two weeks.
Of the 49 patients who had no drugs, 11 said drugs were not supplied and they could not afford to buy them, and 38 did not know they had to use more drugs once their supply was finished.
Discussion
Little is known about why Nigerians whose hypertension was once controlled later lose control. The impression gained from most authors is that economic factors must be dominant,'-4 whereas those from the West make a case for non-compliance, due to such factors as frequency of administration, intolerable side effects, and drug resistance.5-'0
Only three of our patients in this study stopped their drugs because of side effects: extreme weakness in one woman and impotence in two men. In 75% failure of compliance was due to simple misconceptions which could easily have been avoided by proper information. Thirty eight patients did not know they had to continue their drugs; 14 thought they should take the drugs only if they had had a meal; and 13 were unaware which drugs were necessary to control blood pressure.
Simple information together with an explanation of the dangers of untreated hypertension were enough to persuade both the patients with side effects and those who claimed they could not afford drugs to get their drugs regularly and to take them.
Polypharmacy, often with unnecessary drugs, accounted for non-compliance in a few patients, and this is particularly undesirable for patients who have to take drugs for life. Prescriptions should be kept to a minimum. The dusky yellow methyldopa tablet turned out to be racemic alpha-methyldopa, with no indication of the ratio of laevo to dextrorotatory isomers, of which only the former is antihypertensive."1 It is of great concern that 20 years after Aldomet became available unreliable racemic alpha-methyldopa should still be allowed to be dispensed. This hospital pharmacy has since been instructed to stock only Aldomet (MSD), and the two types of methyldopa are shown to each patient and the difference explained. samples. Monoamine oxydase activity was measured radiometrically using C labelled phenylethylamine, tyramine, dopamine, and 5-hydroxytryptamine as substrates. A highly significant decrease in phenylethylamine oxidising ability was observed in migrainous compared with control subjects. In addition, they reported a difference in tyramine oxidation of a similar order and also a smaller decrease in dopamine oxidation. Babies and young children often develop a rash during treatment with penicillin V or amoxycillin. It is sometimes difficult to decide whether this is a viral rash or due to the treatment. Should poliomyelitis vaccine then be withheld from these children or, if given inadvertently, would the result be the recurrence of the rash, or could a more serious reaction occur ? In these circumstances, the benefits of oral polio vaccination would seem to outweigh greatly the risk of allergic reactions to penicillin that has remained in the vaccine from the original seed culture. The maximum amount of penicillin present in the vaccines marketed in Britain is 0-04 units per dose and the chance of an untoward reaction to such a small dose would seem to be remote, particularly when this dose is compared with a starting dose more than 10 times greater than is used in a relatively conservative penicillin desensitisation regimen,' although antihistamine cover would be given in the latter case. To my knowledge, the only well documented report of an allergic reaction to penicillin after polio vaccine given to a 43 year old woman resulted in a relatively mild reaction on each of two occasions when the vaccine was given after earlier penicillin exposure.2 Polio vaccine should be given in the circumstances described and in the rare event of reaction a mild rash with urticaria is the most probable clinical finding. 
